(Q39560387)

13 September 2017

Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A89500

16 April 2022

0 references

P. O. Behan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A89500

16 April 2022

R. A. Shakir

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A89500

16 April 2022

J. A. Simpson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A89500

16 April 2022

A. K. Burnett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A89500

16 April 2022

T. L. Allan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A89500

16 April 2022

G. Haase

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A89500

16 April 2022

language of work or name

English

0 references

publication date

1 September 1979

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0140673679914922?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)91492-2

https://api.elsevier.com/content/article/PII:S0140673679914922?httpAccept=text/plain

16 April 2022

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)91492-2

16 April 2022

1 reference

13 September 2017

2

1 reference

13 September 2017

8140

1 reference

13 September 2017

438-440

1 reference

Myasthenia gravis as an autoimmune disease: clinical aspects

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Letter: Immune response genes in myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

An evaluation of thymectomy in myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

The pathology of the thymus in myasthenia gravis; a study of 35 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Experimental autoimmune myasthenia gravis: cellular and humoral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Myasthenia Gravis: Passive Transfer from Man to Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Remission of myasthenia gravis following plasma-exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Immunosuppressive drugs in treatment of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

EFFECTS OF ADRENOCORTICOTROPHIC HORMONE ON NEURO-MUSCULAR FUNCTION IN PATIENTS WITH MYASTHENIA GRAVIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Method of Removing Abnormal Protein Rapidly from Patients with Malignant Paraproteinaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Plasma exchange in the management of homozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

Long-term effects of repeated plasma exchange in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2991492-2

7 January 2021

British journal of hospital medicine

17

205

552

Plasma exchange (English)

author name string

Pinching

publication date

1978

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)91492-2

16 April 2022

Identifiers

1 reference

13 September 2017

1 reference